Bellevue Group AG 13F holdings
Bellevue Group AG reported 148 positions with a total reported value of $4.8B as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: AMGN AMGEN INC (6.5%), VERX VERTEX PHARMACEUTICALS INC (6.0%), ARGX ARGENX SE (5.9%), GILD GILEAD SCIENCES INC (5.7%), RVMD REVOLUTION MEDICINES INC (4.1%). Against 2026-03-31 it opened 17 new positions and exited 24. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Bellevue Group AG files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
25 largest of 148 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| AMGN AMGEN INC | 851,550 | $308.4M | 6.5% |
| VERX VERTEX PHARMACEUTICALS INC | 578,634 | $287.4M | 6.0% |
| ARGX ARGENX SE | 301,000 | $279.3M | 5.9% |
| GILD GILEAD SCIENCES INC | 2,158,772 | $272.7M | 5.7% |
| RVMD REVOLUTION MEDICINES INC | 1,048,014 | $196.3M | 4.1% |
| ORKA ORUKA THERAPEUTICS INC | 1,657,190 | $157.7M | 3.3% |
| INSM INSMED INC | 1,393,418 | $148.6M | 3.1% |
| SRRK SCHOLAR ROCK HLDG CORP | 2,449,547 | $134.7M | 2.8% |
| NUVL NUVALENT INC | 1,053,268 | $130.1M | 2.7% |
| VIRIDIAN THERAPEUTICS INC | 6,731,909 | $123.7M | 2.6% |
| RLAY RELAY THERAPEUTICS INC | 6,185,970 | $115.7M | 2.4% |
| PCVX VAXCYTE INC | 1,971,935 | $114.6M | 2.4% |
| UTHR UNITED THERAPEUTICS CORP DEL | 188,515 | $102.1M | 2.1% |
| ISRG INTUITIVE SURGICAL INC | 254,809 | $101.3M | 2.1% |
| REGN REGENERON PHARMACEUTICALS | 157,291 | $98.1M | 2.1% |
| CRNX CRINETICS PHARMACEUTICALS IN | 2,620,000 | $98.0M | 2.1% |
| BBIO BRIDGEBIO PHARMA INC | 1,189,506 | $88.6M | 1.9% |
| IMCR IMMUNOCORE HLDGS PLC | 2,788,245 | $88.5M | 1.9% |
| ABT ABBOTT LABORATORIES | 947,115 | $85.9M | 1.8% |
| SYK STRYKER CORPORATION | 268,461 | $84.5M | 1.8% |
| MDT MEDTRONIC PLC | 994,233 | $77.8M | 1.6% |
| IONS IONIS PHARMACEUTICALS INC | 972,258 | $77.1M | 1.6% |
| ELVN ENLIVEN THERAPEUTICS INC | 1,490,000 | $75.6M | 1.6% |
| VERA VERA THERAPEUTICS INC | 1,710,808 | $73.4M | 1.5% |
| JBIO JADE BIOSCIENCES INC | 3,057,996 | $67.9M | 1.4% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 17 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| AVLN AVALYN PHARMACEUTICALS INC | 1,350,000 | $44.4M | 0.9% |
| CGON CG ONCOLOGY INC | 493,596 | $35.1M | 0.7% |
| SPTX SEAPORT THERAPEUTICS INC | 1,100,000 | $23.9M | 0.5% |
| PVLA PALVELLA THERAPEUTICS INC NE | 155,000 | $23.7M | 0.5% |
| SYRE SPYRE THERAPEUTICS INC | 229,931 | $20.4M | 0.4% |
| COAG HEMAB THERAPEUTICS HLDGS INC | 550,000 | $20.2M | 0.4% |
| PBLS PARABILIS MEDICINES INC | 500,000 | $13.7M | 0.3% |
| AURA AURA BIOSCIENCES INC | 1,166,667 | $8.3M | 0.2% |
| MOH MOLINA HEALTHCARE INC | 27,761 | $6.3M | 0.1% |
| GMRS GMR SOLUTIONS INC | 333,333 | $5.2M | 0.1% |
| ALMR ALAMAR BIOSCIENCES INC | 55,738 | $1.5M | <0.1% |
| MOBI MOBIA MED INC | 100,000 | $1.3M | <0.1% |
| MANE VERADERMICS INC | 3,468 | $426.4K | <0.1% |
| DFTX DEFINIUM THERAPEUTICS INC | 8,391 | $394.7K | <0.1% |
| VTRS VIATRIS INC | 15,778 | $250.6K | <0.1% |
| COGT COGENT BIOSCIENCES INC | 4,870 | $188.5K | <0.1% |
| WAT WATERS CORP | 179 | $67.1K | <0.1% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 24 in all · reported value as of 2026-03-31
| Holding | Shares 2026-03-31 | Reported value | % of portfolio then |
|---|---|---|---|
| EWTX EDGEWISE THERAPEUTICS INC | 1,528,518 | $48.1M | 1.1% |
| INSPIRE MED SYS INC | 99,735 | $5.1M | 0.1% |
| PEN PENUMBRA INC | 12,267 | $4.0M | <0.1% |
| RNA ATRIUM THERAPEUTICS INC | 263,096 | $3.5M | <0.1% |
| MASIMO CORP | 8,753 | $1.6M | <0.1% |
| EQNR EQUINOR ASA | 17,573 | $741.6K | <0.1% |
| XOM EXXON MOBIL CORP | 4,370 | $741.4K | <0.1% |
| BP BP PLC | 15,644 | $735.3K | <0.1% |
| SHEL SHELL PLC | 7,844 | $729.5K | <0.1% |
| CSCO CISCO SYS INC | 8,000 | $620.7K | <0.1% |
| BABA ALIBABA GROUP HLDG LTD | 4,700 | $589.7K | <0.1% |
| PG PROCTER & GAMBLE CO | 3,900 | $563.3K | <0.1% |
| MA MASTERCARD INCORPORATED | 1,100 | $549.6K | <0.1% |
| BLK BLACKROCK INC | 450 | $432.8K | <0.1% |
| V VISA INC | 1,400 | $423.1K | <0.1% |
| CENTESSA PHARMACEUTICALS PLC | 9,030 | $358.7K | <0.1% |
| JD JD.COM INC | 11,000 | $325.3K | <0.1% |
| ACN ACCENTURE PLC IRELAND | 1,500 | $297.4K | <0.1% |
| ADBE ADOBE INC | 1,200 | $291.7K | <0.1% |
| OLMA OLEMA PHARMACEUTICALS INC | 16,443 | $245.2K | <0.1% |
| ASND ASCENDIS PHARMA A/S | 536 | $122.6K | <0.1% |
| BBOT BRIDGEBIO ONCOLOGY THERAPEUT | 6,982 | $62.5K | <0.1% |
| WVE WAVE LIFE SCIENCES LTD | 5,261 | $38.1K | <0.1% |
| QGEN QIAGEN NV | 243 | $9.7K | <0.1% |
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| AMGN AMGEN INC | 295,358 | 851,550 | +188.3% | $308.4M |
| INSM INSMED INC | 10,034 | 1,393,418 | +13,787.0% | $148.6M |
| GILD GILEAD SCIENCES INC | 1,169,879 | 2,158,772 | +84.5% | $272.7M |
| ORKA ORUKA THERAPEUTICS INC | 507,008 | 1,657,190 | +226.9% | $157.7M |
| UTHR UNITED THERAPEUTICS CORP DEL | 2,077 | 188,515 | +8,976.3% | $102.1M |
| BBIO BRIDGEBIO PHARMA INC | 25,377 | 1,189,506 | +4,587.3% | $88.6M |
| PCVX VAXCYTE INC | 1,190,697 | 1,971,935 | +65.6% | $114.6M |
| SYK STRYKER CORPORATION | 217,237 | 268,461 | +23.6% | $84.5M |
| CVS CVS HEALTH CORP | 89,363 | 169,366 | +89.5% | $17.5M |
| TMO THERMO FISHER SCIENTIFIC INC | 64,412 | 79,816 | +23.9% | $40.0M |
| IRON DISC MEDICINE INC | 459,314 | 560,000 | +21.9% | $41.0M |
| ALKS ALKERMES PLC | 8,870 | 120,243 | +1,255.6% | $6.3M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| KRYS KRYSTAL BIOTECH INC | 481,785 | 77,530 | -83.9% | $28.8M |
| RVMD REVOLUTION MEDICINES INC | 1,544,456 | 1,048,014 | -32.1% | $196.3M |
| REGN REGENERON PHARMACEUTICALS | 278,674 | 157,291 | -43.6% | $98.1M |
| ALNY ALNYLAM PHARMACEUTICALS INC | 234,543 | 1,092 | -99.5% | $328.7K |
| IONS IONIS PHARMACEUTICALS INC | 1,818,665 | 972,258 | -46.5% | $77.1M |
| SRRK SCHOLAR ROCK HLDG CORP | 3,584,573 | 2,449,547 | -31.7% | $134.7M |
| TNGX TANGO THERAPEUTICS INC | 2,400,000 | 694,182 | -71.1% | $21.7M |
| VERX VERTEX PHARMACEUTICALS INC | 681,908 | 578,634 | -15.1% | $287.4M |
| ELVN ENLIVEN THERAPEUTICS INC | 2,320,867 | 1,490,000 | -35.8% | $75.6M |
| RLAY RELAY THERAPEUTICS INC | 7,795,242 | 6,185,970 | -20.6% | $115.7M |
| BSX BOSTON SCIENTIFIC CORP | 1,466,894 | 887,650 | -39.5% | $37.9M |
| CRNX CRINETICS PHARMACEUTICALS IN | 3,280,000 | 2,620,000 | -20.1% | $98.0M |
CIK 1674546 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
